An Observational Study to Describe Women Exposed to Apremilast During Pregnancy and Infant Outcomes During the First Year of Life (20210218)

06/12/2023
12/05/2025
EU PAS number:
EUPAS107685
Study
Finalised
Documents
Study protocol
Initial protocol
English (875.11 KB - PDF) View document
Study results
Study results
English (904.44 KB - PDF) View document
Study report
Other information